Literature DB >> 18008393

A preliminary investigation of the reliability and validity of the Brief Assessment Schedule Depression Cards and the Beck Depression Inventory-Fast Screen to screen for depression in older stroke survivors.

A K Healey1, I I Kneebone, M Carroll, S J Anderson.   

Abstract

OBJECTIVE: To conduct an initial assessment of the reliability and validity of the Brief Assessment Schedule Depression Cards (BASDEC) and the Beck Depression Inventory-Fast Screen (BDI-FS) to screen for depression in older stroke survivors.
METHODS: Participants from four inpatient rehabilitation units completed the BASDEC and the BDI-FS together with the Hospital Anxiety and Depression Scale (HADS) for comparison. The Structured Clinical Interview for DSM-IV Axis 1 Disorders (SCID) was then completed with all participants to ascertain a criterion depression diagnosis. The BASDEC and BDI-FS were subsequently completed for a second time.
RESULTS: Forty-nine stroke survivors (M=78.80, SD=6.79 years) were included. The BASDEC and BDI-FS demonstrated acceptable internal consistency and test-retest reliability. The BASDEC (cut-off >or=7) resulted in a sensitivity of 1.0 and specificity of 0.95 for detecting major depression whereas the BDI-FS (cut-off >or=4) had a sensitivity of 0.71 and specificity of 0.74. When participants with minor depression were included in analyses, sensitivity lowered to 0.69 (specificity=0.97) for the BASDEC and 0.62 (specificity=0.78) for the BDI-FS.
CONCLUSIONS: The BASDEC and BDI-FS were found to have acceptable reliability. The BASDEC demonstrated some advantage in criterion validity over the BDI-FS at the examined cut-offs.

Entities:  

Mesh:

Year:  2008        PMID: 18008393     DOI: 10.1002/gps.1933

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  9 in total

1.  Comparison of depressive symptom severity scores in low-income women.

Authors:  Shawn M Kneipp; John A Kairalla; Jeanne Marie R Stacciarini; Deidre Pereira; M David Miller
Journal:  Nurs Res       Date:  2010 Nov-Dec       Impact factor: 2.381

Review 2.  Case identification of depression in patients with chronic physical health problems: a diagnostic accuracy meta-analysis of 113 studies.

Authors:  Nicholas Meader; Alex J Mitchell; Carolyn Chew-Graham; David Goldberg; Maria Rizzo; Victoria Bird; David Kessler; Jon Packham; Mark Haddad; Stephen Pilling
Journal:  Br J Gen Pract       Date:  2011-12       Impact factor: 5.386

Review 3.  Gene-environment interactions in geriatric depression.

Authors:  Francis E Lotrich
Journal:  Psychiatr Clin North Am       Date:  2011-06

4.  Low depressive symptoms in acute spinal cord injury compared to other neurological disorders.

Authors:  Katayun Hassanpour; Sabina Hotz-Boendermaker; Petra Dokladal; Armin Curt
Journal:  J Neurol       Date:  2011-11-18       Impact factor: 4.849

5.  Validation of two depression screening instruments in a sleep disorders clinic.

Authors:  Mandy Law; Matthew T Naughton; Arup Dhar; David Barton; Eli Dabscheck
Journal:  J Clin Sleep Med       Date:  2014-06-15       Impact factor: 4.062

6.  Management of depression in elderly stroke patients.

Authors:  Johan Lökk; Ahmad Delbari
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

7.  Improved Detection and Evaluation of Depression in Patients with Chronic Kidney Disease: Validity and Reliability of Screening (PHQ-2) and Diagnostic (BDI-FS-Fr) Tests of Depression in Chronic Kidney Disease.

Authors:  Muaweah Alsaleh; Ludivine Videloup; Thierry Lobbedez; Joelle Lebreuilly; Remy Morello; Angélique Thuillier Lecouf
Journal:  Kidney Dis (Basel)       Date:  2019-03-25

8.  Emerging strategies in the treatment of poststroke depression and psychiatric distress in patients.

Authors:  Vincent F Capaldi; Gary H Wynn
Journal:  Psychol Res Behav Manag       Date:  2010-12-06

9.  Treating anxiety after stroke using cognitive-behaviour therapy: two cases.

Authors:  Ian I Kneebone; Fiona W Jeffries
Journal:  Neuropsychol Rehabil       Date:  2013-07-26       Impact factor: 2.868

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.